Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia

Spinal Cord

Volumn 49, Issue 5, 2011, Pages 659-664

  Chen, C Y ^a   Liao, C H ^b   Kuo, H C ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

botulinum toxin; neurogenic bladder; spinal cord injury; urodynamics

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DEMOGRAPHY; DETRUSOR DYSSYNERGIA; DRUG EFFECT; FEMALE; HUMAN; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; SPINAL CORD INJURY; TREATMENT OUTCOME; URODYNAMICS;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; MALE; MIDDLE AGED; SPINAL CORD INJURIES; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; YOUNG ADULT;

EID: 79955876073     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2010.179     Document Type: Article

References (21)

1. Weld KJ, Graney MJ, Dmochowski RR. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology 2000; 56: 565-568.
2. Bennet N, O'Leary M, Patel AS, Xavier M, Erickson JR, Chancellor MB. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol 2004; 171: 749-751. (Pubitemid 38090473)
3. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drug? Preliminary results. J Urol 2000; 164: 692-697. (Pubitemid 30637604)
4. Reitz A, Stohrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45: 510-515. (Pubitemid 38376219)
5. Karsenty G, Denys P, Amarenco G, Gamé X, Mouracade P, Chartier-Kastler E et al. Botulinum toxin A (Botox) intradetrus or injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 2008; 53: 275-287. (Pubitemid 350296587)
6. Blaivas JG, SinhaHP, Zayed AA, Labib KB. Detrusor-external sphincterdyssynergia: a detailed electromyographic study. J Urol 1981; 125: 545-548. (Pubitemid 11116658)
7. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. for the continence program for women research group. Short forms to assess life quality and symptom distress for urinary incontinence in women: The incontinence impact questionnaire and the urogenital distress inventory. Neurourol Urodyn 1995; 14: 131-139.
8. Cockett A, Aso Y, Denis L, Khoury S, Barry M, Carlton CE et al. Recommendation of the International Consensus Committee concerning: 1 Prostate symptom score and quality of life assessment. In: Cockett ATK, Khoury S, Aso Y, et al, (eds). Proceedings, The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 27-30, 1993. Scientific Communica-tion International Ltd: Channel Island, Jersey, 1994, 553-555.
9. Maynard Jr FM, Bracken MB, Creasey G, Ditunno Jr JF, Donovan WH, Ducker TB et al. International standards for neurological and functional Classication of spinal cord injury. American Spinal Injury Association. Spinal Cord 1997; 35: 266-274. (Pubitemid 27235039)
10. Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor over-activity. Urology 2006; 68: 1193-1197. (Pubitemid 44880353)
11. Kalsi V, Apostolidis A, Popat R, Gonzales G, Fowler CJ, Dasgupta P. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 2006; 49: 528-535. (Pubitemid 43259564)
12. Bagi P, Biering-Sorensen F. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions. Scand J Urol Nephrol 2004; 38: 495-498. (Pubitemid 39665416)
13. McGuire EJ, Savastano JA. Urodynamics and management of the neuropathic bladder in spinal cord injury patients. J Am Paraplegia Soc 1985; 8: 28-32.
14. Apostolidis A, Dasgupta P, Fowler CJ. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 2006; 49: 644-650. (Pubitemid 43374724)
15. Smet PJ, Moore KH, Jonavicius J. Distribution and co-localization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 1997; 77: 37-49. (Pubitemid 27328358)
16. Klaphajone J, Kitisomprayoonkul W, Sriplakit S. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys Med Rehabil 2005; 86: 2114-2118. (Pubitemid 41566206)
17. Schurch B, Schmid DM, Karsenty G, Reitz A. Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury? Urology 2005; 65: 243-246. (Pubitemid 40248005)
18. Kuo HC. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection. Urology 2008; 72: 1056-1060.
19. Kuo HC. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003; 170: 1908-1912.
20. Grosse J, Kramer G, Stohrer M. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005; 47: 653-659. (Pubitemid 40521915)
21. Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol 2007; 52: 850-858.